← Leaderboards
Alison Nicole McCracken
Siege Pharmaceuticals, Inc.
$1,287,564
Attributed
$1,287,564
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $989.4K · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$1,287,564 · 2
By mechanism
R44$989,405 · 1
R43$298,159 · 1
Top collaborators
No co-investigators on record.
Most similar at Siege Pharmaceuticals, Inc.
Same institution · by research overlap
- Daniel Gil$1,008,833
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsFda ApprovedOralPharmacologic SubstanceCharacteristicsCellsEfficacy EvaluationNormal Tissue MorphologyPreventToxic EffectFundingBiological AvailabilityAmino AcidsBiological ModelsBiochemicalBenchmarkingAmericanAffectCanis FamiliarisAnti-Inflammatory AgentsCancer TherapyCardiovascular Disorder RiskCardiovascular SystemCancer Patient